Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients

Kenneth K. Sakata, Christine L. Klassen, Kathryn B. Bollin, Thomas Grys, James L Slack, Lewis J. Wesselius, Holenarasipur R. Vikram

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: Stem cell transplant (SCT) recipients commonly undergo bronchoalveolar lavage (BAL) collection as an infectious pulmonary work-up. Previous studies report the utility and overall diagnostic yield of fiberoptic bronchoscopy with BAL in this vulnerable population, though none focused purely on microbiologic yield or made comparisons with less invasive means of pathogen detection. We sought to determine and elaborate on the microbiologic yield of BAL in SCT recipients, assess a correlation between BAL studies and less invasive means of pathogen detection, and assess the utility of repeating a BAL within 30 days. Methods: Between January 1, 2009, and July 31, 2013, we reviewed medical records of 125 SCT recipients who underwent 179 BALs. In addition to demographic information and details pertaining to their SCT, a comprehensive review of their microbiologic data was performed and recorded. Results: Our study showed an overall BAL microbiologic yield of 40%, despite 92% of patients receiving broad-spectrum antimicrobial therapy at the time of the BAL procedure. Conclusions: Although an initial BAL sample in this population provides crucial microbiologic information, repeating the procedure within 30 days may have minimal additional microbiologic yield. BAL continues to be an essential diagnostic tool in SCT recipients undergoing an infectious pulmonary work-up.

Original languageEnglish (US)
Article numbere12684
JournalTransplant Infectious Disease
Volume19
Issue number3
DOIs
StatePublished - Jun 1 2017

Fingerprint

Bronchoalveolar Lavage
Stem Cells
Transplants
Transplant Recipients
Dimercaprol
Lung
Bronchoscopy
Vulnerable Populations
Medical Records
Demography

Keywords

  • bone marrow transplant
  • bronchoalveolar lavage
  • fiberoptic bronchoscopy
  • immunocompromised
  • immunosuppressed
  • stem cell transplant

ASJC Scopus subject areas

  • Transplantation
  • Infectious Diseases

Cite this

Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients. / Sakata, Kenneth K.; Klassen, Christine L.; Bollin, Kathryn B.; Grys, Thomas; Slack, James L; Wesselius, Lewis J.; Vikram, Holenarasipur R.

In: Transplant Infectious Disease, Vol. 19, No. 3, e12684, 01.06.2017.

Research output: Contribution to journalArticle

Sakata, Kenneth K. ; Klassen, Christine L. ; Bollin, Kathryn B. ; Grys, Thomas ; Slack, James L ; Wesselius, Lewis J. ; Vikram, Holenarasipur R. / Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients. In: Transplant Infectious Disease. 2017 ; Vol. 19, No. 3.
@article{f226ce4a0ccc4f44b14662ebe7015b54,
title = "Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients",
abstract = "Purpose: Stem cell transplant (SCT) recipients commonly undergo bronchoalveolar lavage (BAL) collection as an infectious pulmonary work-up. Previous studies report the utility and overall diagnostic yield of fiberoptic bronchoscopy with BAL in this vulnerable population, though none focused purely on microbiologic yield or made comparisons with less invasive means of pathogen detection. We sought to determine and elaborate on the microbiologic yield of BAL in SCT recipients, assess a correlation between BAL studies and less invasive means of pathogen detection, and assess the utility of repeating a BAL within 30 days. Methods: Between January 1, 2009, and July 31, 2013, we reviewed medical records of 125 SCT recipients who underwent 179 BALs. In addition to demographic information and details pertaining to their SCT, a comprehensive review of their microbiologic data was performed and recorded. Results: Our study showed an overall BAL microbiologic yield of 40{\%}, despite 92{\%} of patients receiving broad-spectrum antimicrobial therapy at the time of the BAL procedure. Conclusions: Although an initial BAL sample in this population provides crucial microbiologic information, repeating the procedure within 30 days may have minimal additional microbiologic yield. BAL continues to be an essential diagnostic tool in SCT recipients undergoing an infectious pulmonary work-up.",
keywords = "bone marrow transplant, bronchoalveolar lavage, fiberoptic bronchoscopy, immunocompromised, immunosuppressed, stem cell transplant",
author = "Sakata, {Kenneth K.} and Klassen, {Christine L.} and Bollin, {Kathryn B.} and Thomas Grys and Slack, {James L} and Wesselius, {Lewis J.} and Vikram, {Holenarasipur R.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1111/tid.12684",
language = "English (US)",
volume = "19",
journal = "Transplant Infectious Disease",
issn = "1398-2273",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients

AU - Sakata, Kenneth K.

AU - Klassen, Christine L.

AU - Bollin, Kathryn B.

AU - Grys, Thomas

AU - Slack, James L

AU - Wesselius, Lewis J.

AU - Vikram, Holenarasipur R.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Purpose: Stem cell transplant (SCT) recipients commonly undergo bronchoalveolar lavage (BAL) collection as an infectious pulmonary work-up. Previous studies report the utility and overall diagnostic yield of fiberoptic bronchoscopy with BAL in this vulnerable population, though none focused purely on microbiologic yield or made comparisons with less invasive means of pathogen detection. We sought to determine and elaborate on the microbiologic yield of BAL in SCT recipients, assess a correlation between BAL studies and less invasive means of pathogen detection, and assess the utility of repeating a BAL within 30 days. Methods: Between January 1, 2009, and July 31, 2013, we reviewed medical records of 125 SCT recipients who underwent 179 BALs. In addition to demographic information and details pertaining to their SCT, a comprehensive review of their microbiologic data was performed and recorded. Results: Our study showed an overall BAL microbiologic yield of 40%, despite 92% of patients receiving broad-spectrum antimicrobial therapy at the time of the BAL procedure. Conclusions: Although an initial BAL sample in this population provides crucial microbiologic information, repeating the procedure within 30 days may have minimal additional microbiologic yield. BAL continues to be an essential diagnostic tool in SCT recipients undergoing an infectious pulmonary work-up.

AB - Purpose: Stem cell transplant (SCT) recipients commonly undergo bronchoalveolar lavage (BAL) collection as an infectious pulmonary work-up. Previous studies report the utility and overall diagnostic yield of fiberoptic bronchoscopy with BAL in this vulnerable population, though none focused purely on microbiologic yield or made comparisons with less invasive means of pathogen detection. We sought to determine and elaborate on the microbiologic yield of BAL in SCT recipients, assess a correlation between BAL studies and less invasive means of pathogen detection, and assess the utility of repeating a BAL within 30 days. Methods: Between January 1, 2009, and July 31, 2013, we reviewed medical records of 125 SCT recipients who underwent 179 BALs. In addition to demographic information and details pertaining to their SCT, a comprehensive review of their microbiologic data was performed and recorded. Results: Our study showed an overall BAL microbiologic yield of 40%, despite 92% of patients receiving broad-spectrum antimicrobial therapy at the time of the BAL procedure. Conclusions: Although an initial BAL sample in this population provides crucial microbiologic information, repeating the procedure within 30 days may have minimal additional microbiologic yield. BAL continues to be an essential diagnostic tool in SCT recipients undergoing an infectious pulmonary work-up.

KW - bone marrow transplant

KW - bronchoalveolar lavage

KW - fiberoptic bronchoscopy

KW - immunocompromised

KW - immunosuppressed

KW - stem cell transplant

UR - http://www.scopus.com/inward/record.url?scp=85017546260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017546260&partnerID=8YFLogxK

U2 - 10.1111/tid.12684

DO - 10.1111/tid.12684

M3 - Article

C2 - 28218980

AN - SCOPUS:85017546260

VL - 19

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

SN - 1398-2273

IS - 3

M1 - e12684

ER -